Placebo to Match Tinlarebant (LBS-008). Placebo tablets will be prepared similarly with microcrystalline cellulose used in place of the active drug substance. The placebo tablet is identical in size, appearance, and other physical properties to the LBS-008 tablet., LBS-008
LBS-008-CT05
Phase 3 small_molecule active
Quick answer
Placebo to Match Tinlarebant (LBS-008). Placebo tablets will be prepared similarly with microcrystalline cellulose used in place of the active drug substance. The placebo tablet is identical in size, appearance, and other physical properties to the LBS-008 tablet., LBS-008 for Geographic Atrophy is a Phase 3 program (small_molecule) at ELITE PHARMACEUTICALS INC /NV/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ELITE PHARMACEUTICALS INC /NV/
- Indication
- Geographic Atrophy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active